EMJ GOLD - European Medical Journal

Continue

Pharma News, Views & Analysis

Filter Advertise With Us
Angelo Auricchio

Boston Scientific’s Angelo Auricchio on what’s next for heart health

Discover what’s on the horizon for cardiac care and remote monitoring with Angelo Auricchio, Chief Medical Officer, Rhythm Management, Boston Scientific.
HBA CEO Mary Stutts

The HBA’s Mary Stutts on tackling bias for better women’s health

Mary Stutts, CEO, HBA, unpacks the key findings of a report exposing critical gaps in doctors’ understanding of women’s health.
Jade Williams and Isabel O'Brien, EMJ GOLD

Does interactivity boost memory, recall and retention?

Explore the science behind memory, recall and retention, and uncover why interactive content could be the future in this podcast.
Martin Price, J&J

J&J’s Martin Price on World Cancer Day 2025 – Part 2

Uncover more of Martin Price, Vice President, Health Economics, Market Access and Reimbursement, EMEA, Johnson & Johnson’s thoughts on the oncology space

J&J’s Martin Price on World Cancer Day 2025 – Part 1

A World Cancer Day edition of the podcast, with Martin Price, Vice President, Health Economics, Market Access and Reimbursement, EMEA, J&J.
Charl van Zyl, Lundbeck Pharmaceuticals

Lundbeck’s Charl van Zyl on a new era in neurology

The team are joined by Charl van Zyl, President and CEO, Lundbeck Pharmaceuticals, to discuss advances in the treatment of neurological disorders.

The 2025 pharma forecast

Curious to know could happen in the industry in 2025? Join us as we talk to three guests about their top predictions for the year ahead.

Pharma review of the year 2024

Look back at the key moments from the past year in pharma with three of our former guests, as they highlight key trends, challenges and more.